Search

Search Constraints

You searched for: Author/Creator Finetti, Pascal

Search Results

2. The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer. Issue 11 (27th November 2018)

3. A genome‐wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells. Issue 10 (2nd September 2019)

4. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers. Issue 3 (5th February 2020)

5. Systems biology analysis of gene expression data and gene network reverse-engineering approaches reveal NFAT5 as a candidate biomarker in Inflammatory Breast Cancer. (14th August 2015)

6. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Issue 10 (27th August 2021)

8. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. Issue 1 (10th January 2022)

9. Brief Reports: A Distinct DNA Methylation Signature Defines Breast Cancer Stem Cells and Predicts Cancer Outcome. (14th October 2014)